| 000 | 01667 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250512000704.0 | ||
| 264 | 0 | _c19900409 | |
| 008 | 199004s 0 0 eng d | ||
| 022 | _a0271-0749 | ||
| 024 | 7 |
_a10.1097/00004714-199002000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCiraulo, D A | |
| 245 | 0 | 0 |
_aThe relationship of alprazolam dose to steady-state plasma concentrations. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cFeb 1990 |
||
| 300 |
_a27-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAgoraphobia _xblood |
| 650 | 0 | 4 |
_aAlprazolam _xadministration & dosage |
| 650 | 0 | 4 |
_aAnxiety Disorders _xblood |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aFear _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPanic _xdrug effects |
| 650 | 0 | 4 | _aPersonality Tests |
| 700 | 1 | _aAntal, E J | |
| 700 | 1 | _aSmith, R B | |
| 700 | 1 | _aOlson, D R | |
| 700 | 1 | _aGoldberg, D A | |
| 700 | 1 | _aRand, E H | |
| 700 | 1 | _aRaskin, R B | |
| 700 | 1 | _aPhillips, J P | |
| 700 | 1 | _aShader, R I | |
| 700 | 1 | _aGreenblatt, D J | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 10 _gno. 1 _gp. 27-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004714-199002000-00005 _zAvailable from publisher's website |
| 999 |
_c2413809 _d2413809 |
||